Tag

FDA

IMS Drug Report

By | Commentary | No Comments

IMS has a tremendous amount of information on prescription drug use and their reports are always worth paying attention to. The latest provides their outlook through 2016, finding steady increases in overall global spending, with less on brand names and more on generic.

Read More

2012 Potpourri VIII

By | Commentary | No Comments

Its March and spring nears; our Potpourri blooms with nuggets of health care information, including comparative regulation of medical devices in the US and Europe, do physicians always truthful with patients, CMS’ oversight of home health care agencies, the validity of a CMS’ measure of ER scanning, and patient-centered care.

Read More